Comparison between Clinitech Laboratory IPO and RNFI Services IPO.
Clinitech Laboratory IPO is a SME Bookbuilding IPO proposed to list at BSE SME while RNFI Services IPO is a SME Bookbuilding proposed to list at NSE SME.
| Clinitech Laboratory IPO | RNFI Services IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Inventure Merchant Banker Services Pvt.Ltd. | Choice Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | Svcm Securities Pvt.Ltd. | Choice Equity Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Clinitech Laboratory IPO is up to ₹5.48 Cr whereas the issue size of the RNFI Services IPO is up to ₹66.78 Cr. The final issue price of Clinitech Laboratory IPO is ₹96.00 per share and of RNFI Services IPO is ₹105.00 per share.
| Clinitech Laboratory IPO | RNFI Services IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹98.00 per share | |
| Issue Price (Upper) | ₹105.00 per share | |
| Issue Price (Final) | ₹96.00 per share | ₹105.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1200 shares | 1200 shares |
| Fresh Issue Size | 5,71,200 shares | 63,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹5.48 Cr | up to ₹66.78 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 5,71,200 shares | 63,60,000 shares |
| Issue Size Total (Amount) | up to ₹5.48 Cr | up to ₹66.78 Cr |
Clinitech Laboratory IPO opens on Jul 25, 2024, while RNFI Services IPO opens on Jul 22, 2024. The closing date of Clinitech Laboratory IPO and RNFI Services IPO is Jul 29, 2024, and Jul 24, 2024, respectively.
| Clinitech Laboratory IPO | RNFI Services IPO | |
|---|---|---|
| Anchor Bid Date | Jul 19, 2024 | |
| Issue Open | Jul 25, 2024 | Jul 22, 2024 |
| Issue Close | Jul 29, 2024 | Jul 24, 2024 |
| Basis Of Allotment (Tentative) | Jul 30, 2024 | Jul 25, 2024 |
| Initiation of Refunds (Tentative) | Jul 31, 2024 | Jul 26, 2024 |
| Credit of Share (Tentative) | Jul 31, 2024 | Jul 26, 2024 |
| Listing date (Tentative) | Aug 01, 2024 | Jul 29, 2024 |
| Anchor Lockin End date 1 | Aug 24, 2024 | |
| Anchor Lockin End date 2 | Oct 23, 2024 |
Clinitech Laboratory IPO P/E ratio is 43.45, as compared to RNFI Services IPO P/E ratio of 19.19.
| Clinitech Laboratory IPO | RNFI Services IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Clinitech Laboratory Limited Financial Information (Restated)Clinitech Laboratory Limited's revenue increased by 1.19% and profit after tax (PAT) dropped by -39.46% between the financial year ending with March 31, 2024 and March 31, 2023.
| RNFI Services Limited Financial Information (Restated Consolidated)RNFI Services Limited's revenue decreased by -11.81% and profit after tax (PAT) rose by 103.82% between the financial year ending with March 31, 2024 and March 31, 2023.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 83.63 | 89.53 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 61.56 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 43.45 | 19.19 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹21.91 Cr. | ₹262.00 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 29.74% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.24 | 1.02 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹2.21 | ₹5.47 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 10.46% | 40.92% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Clinitech Laboratory IPO Retail Individual Investors (RII) are offered 2,85,600 shares while in RNFI Services IPO retail investors are offered 2,85,600 shares. Qualified Institutional Buyers (QIB) are offered in Clinitech Laboratory IPO and 12,72,000 shares in RNFI Services IPO.
| Clinitech Laboratory IPO | RNFI Services IPO | |
|---|---|---|
| Anchor Investor Reserveration | 19,08,000 shares | |
| Market Maker Reserveration | 31,200 shares | 3,84,000 shares |
| QIB | 12,72,000 shares | |
| NII | 2,85,600 shares | 9,54,000 shares |
| RII | 2,85,600 shares | 22,26,000 shares |
| Employee | ||
| Others | ||
| Total | 5,71,200 shares | 63,60,000 shares |
Clinitech Laboratory IPO subscribed 38.96x in total, whereas RNFI Services IPO subscribed 221.49x.
| Clinitech Laboratory IPO | RNFI Services IPO | |
|---|---|---|
| QIB (times) | 140.66x | |
| NII (times) | 23.28x | 513.31x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 49.61x | 142.62x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 38.96x | 221.49x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
